I 
109TH CONGRESS 
1ST SESSION H. R. 3781 
To accelerate efforts to develop vaccines for diseases primarily affecting 
developing countries, and for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
SEPTEMBER 14, 2005 
Mr. VISCLOSKY introduced the following bill; which was referred to the Com-
mittee on Ways and Means, and in addition to the Committees on Inter-
national Relations, Energy and Commerce, Small Business, and Financial 
Services, for a period to be subsequently determined by the Speaker, in 
each case for consideration of such provisions as fall within the jurisdic-
tion of the committee concerned 
A BILL 
To accelerate efforts to develop vaccines for diseases pri-
marily affecting developing countries, and for other pur-
poses. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Vaccines for the New 
Millennium Act of 2005’’. 
SEC. 2. DEFINITIONS. 
In this Act:
(1) AIDS.—The term ‘‘AIDS’’ has the meaning 
given the term in section 104A(g) of the Foreign As-
sistance Act of 1961 (22 U.S.C. 2151b–2). 
(2) APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES.—The term ‘‘appropriate congressional com-
mittees’’ means the Committee on Appropriations 
and the Committee on Foreign Relations of the Sen-
ate and the Committee on Appropriations and the 
Committee on International Relations of the House 
of Representatives. 
(3) DEVELOPING COUNTRY.—The term ‘‘devel-
oping country’’ means a country that the World 
Bank determines to be a country with a lower mid-
dle income or less. 
(4) HIV/AIDS.—The term ‘‘HIV/AIDS’’ has 
the meaning given the term in section 104A(g) of 
the Foreign Assistance Act of 1961 (22 U.S.C. 
2151b–2). 
(5) GLOBAL ALLIANCE FOR VACCINES AND IM-
MUNIZATIONS.—The term ‘‘Global Alliance for Vac-
cines and Immunizations’’ means the public-private 
partnership launched in 2000 for the purpose of sav-
ing the lives of children and protecting the health of 
all people through the widespread use of vaccines.
(6) NEGLECTED
DISEASE.—The term ‘‘ne-
glected disease’’ means— 
(A) HIV/AIDS; 
(B) malaria; 
(C) tuberculosis; or 
(D) any infectious disease (of a single eti-
ology), which, according to the World Health 
Organization, causes more than 1,000,000 
deaths each year in developing countries. 
(7) WORLD BANK.—The term ‘‘World Bank’’ 
means the International Bank for Reconstruction 
and Development. 
SEC. 3. FINDINGS. 
Congress makes the following findings: 
(1) Immunization is cheap, reliable, and effec-
tive, and has made a profound impact on global 
health, in both rich and poor countries. 
(2) During the 20th century, global immuniza-
tion efforts have successfully led to the eradication 
of smallpox and the elimination of polio from the 
Western Hemisphere, Europe, and most of Asia. 
Vaccines for diseases such as measles and tetanus 
have dramatically reduced childhood mortality world-
wide, and vaccines for diseases such as influenza,
pneumonia, and hepatitis help prevent sickness and 
death of adults as well as children. 
(3) According to the World Health Organiza-
tion, combined, AIDS, tuberculosis, and malaria kill 
more than 5,000,000 people a year, most of whom 
are in the developing world, yet there are no vac-
cines for these diseases. 
(4) It is estimated that just 10 percent of the 
world’s research and development on health is tar-
geted on diseases affecting 90 percent of the world’s 
population. 
(5) Economic disincentives result in little pri-
vate sector investment in vaccines for neglected dis-
eases, a situation which disproportionately affects 
populations in developing countries. 
(6) Of more than $100,000,000,000 spent on 
health research and development across the world, 
only $6,000,000,000 is spent each year on diseases 
that are specific to developing countries, most of 
which is from public and philanthropic sources. 
(7) Infants, children, and adolescents are 
among the populations hardest hit by AIDS and ma-
laria, but they are at risk of being left behind in the 
search for effective vaccines against such diseases.
(8) Providing a broad range of economic incen-
tives to increase private sector research on neglected 
diseases, including increased public and private sec-
tor funding for research and development, guaran-
teed markets, tax credits, and improved regulatory 
procedures would increase the number of products in 
development and the likelihood of finding effective 
vaccines for such diseases. 
SEC. 4. SENSE OF CONGRESS ON SUPPORT FOR NE-
GLECTED DISEASES. 
It is the sense of Congress that— 
(1) the President should continue to encourage 
efforts to support the Global HIV Vaccine Enter-
prise, a virtual consortium of scientists and organi-
zations committed to accelerating the development of 
an effective HIV vaccine; 
(2) the United States should work with the 
Global Fund to Fight AIDS, Tuberculosis and Ma-
laria, the Joint United Nations Programme on HIV/ 
AIDS (‘‘UNAIDS’’), the World Health Organiza-
tion, the International AIDS Vaccine Initiative, and 
the World Bank to ensure that all countries heavily 
affected by the HIV/AIDS pandemic have national 
AIDS vaccine plans;